These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34396463)

  • 21. Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Roubaud-Baudron C; Pagnoux C; Méaux-Ruault N; Grasland A; Zoulim A; LE Guen J; Prud'homme A; Bienvenu B; de Menthon M; Camps S; LE Guern V; Aouba A; Cohen P; Mouthon L; Guillevin L;
    J Rheumatol; 2012 Jan; 39(1):125-30. PubMed ID: 22089465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adalimumab for the treatment of uveitis.
    LaMattina KC; Goldstein DA
    Expert Rev Clin Immunol; 2017 Mar; 13(3):181-188. PubMed ID: 28140700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
    Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
    Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-CD 20 monoclonal antibody (rituximab) treatment for inflammatory ocular diseases.
    Miserocchi E; Pontikaki I; Modorati G; Gattinara M; Meroni PL; Gerloni V
    Autoimmun Rev; 2011 Nov; 11(1):35-9. PubMed ID: 21763790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asthma control in eosinophilic granulomatosis with polyangiitis treated with rituximab.
    Casal Moura M; Berti A; Keogh KA; Volcheck GW; Specks U; Baqir M
    Clin Rheumatol; 2020 May; 39(5):1581-1590. PubMed ID: 31897956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.
    Crayne CB; Eloseily E; Mannion ML; Azerf SP; Weiser P; Beukelman T; Stoll ML; Feig DI; Prescott Atkinson T; Cron RQ
    Pediatr Rheumatol Online J; 2018 Nov; 16(1):71. PubMed ID: 30428889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between advanced glycation end products and uveitis/scleritis activity in patients with active immune-mediated ocular inflammatory diseases.
    Sukon N; Choopong P; Tungsattayathitthan U; Tesavibul N; Sanpan W; Boonsopon S
    Int Ophthalmol; 2024 Feb; 44(1):33. PubMed ID: 38329659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive profiling of extracellular vesicles in uveitis and scleritis enables biomarker discovery and mechanism exploration.
    Wu L; Zhou L; An J; Shao X; Zhang H; Wang C; Zhao G; Chen S; Cui X; Zhang X; Yang F; Li X; Zhang X
    J Transl Med; 2023 Jun; 21(1):388. PubMed ID: 37322475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The "4 plus 2" rituximab protocol makes maintenance treatment unneeded in patients with refractory ANCA-associated vasculitis: A 10 years observation study.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Radin M; Fenoglio R; Baldovino S; Menegatti E
    Oncotarget; 2017 Aug; 8(32):52072-52077. PubMed ID: 28881714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics, evolution, and outcome of patients with non-infectious uveitis referred for rheumatologic assessment and management: an Egyptian multicenter retrospective study.
    Hassan WA; Medhat BM; Youssef MM; Farag Y; Mostafa N; Alnaggar AR; Behiry ME; Abdel Noor RA; Allam RSHM
    Clin Rheumatol; 2021 Apr; 40(4):1599-1610. PubMed ID: 32876781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rituximab use in young adults diagnosed with juvenile idiopathic arthritis unresponsive to conventional treatment: report of 6 cases.
    Sakamoto AP; Pinheiro MM; Barbosa CM; Fraga MM; Len CA; Terreri MT
    Rev Bras Reumatol; 2015; 55(6):536-41. PubMed ID: 26066294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methotrexate as a first-line corticosteroid-sparing therapy in a cohort of uveitis and scleritis.
    Kaplan-Messas A; Barkana Y; Avni I; Neumann R
    Ocul Immunol Inflamm; 2003 Jun; 11(2):131-9. PubMed ID: 14533032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of long-term infliximab use and impact of treatment adherence on disease control in refractory, non-infectious pediatric uveitis.
    Miraldi Utz V; Bulas S; Lopper S; Fenchel M; Sa T; Mehta M; Ash D; Lovell DJ; Kaufman AH
    Pediatr Rheumatol Online J; 2019 Nov; 17(1):79. PubMed ID: 31783768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A case of scleritis associated rheumatoid arthritis accompanying an intraocular elevated lesion.
    Kobayashi T; Takai N; Tada R; Shoda H; Kida T; Ikeda T; Ozaki T; Makino S
    BMC Ophthalmol; 2018 May; 18(1):129. PubMed ID: 29843653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort.
    French DD; Margo CE
    Retina; 2008 Jun; 28(6):889-93. PubMed ID: 18536608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar).
    Vacchi C; Visentini M; Gragnani L; Fraticelli P; Tavoni A; Filippini D; Saccardo F; Lauletta G; Colantuono S; Atzeni F; Pioltelli P; Manfredi A; Casato M; Zignego AL; Monti G; Pietrogrande M; Galli M; Sebastiani M
    Intern Emerg Med; 2021 Jan; 16(1):149-156. PubMed ID: 32524338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive Factors.
    Kempen JH; Pistilli M; Begum H; Fitzgerald TD; Liesegang TL; Payal A; Zebardast N; Bhatt NP; Foster CS; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Sen HN; Suhler EB; Thorne JE;
    Am J Ophthalmol; 2021 Mar; 223():377-395. PubMed ID: 30951689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
    Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
    Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.